Literature DB >> 20730442

Subconjunctival reflux and need for paracentesis after intravitreal injection of 0.1 ml bevacizumab: comparison between 27-gauge and 30-gauge needle.

Katrin Lorenz1, Isabella Zwiener, Alireza Mirshahi.   

Abstract

PURPOSE: Intravitreal injections may lead to a significant elevation of the intraocular pressure (IOP). A paracentesis may become necessary for acute reduction of the IOP in certain cases. The purpose of this study was to determine the frequency of paracentesis performed and the grade of reflux under the conjunctiva after injection of 0.1 ml bevacizumab (1.25 mg), depending on the thickness of the needles used.
METHODS: A retrospective review was undertaken of the surgery reports of 234 consecutive intravitreal bevacizumab injections in 145 eyes of 144 patients within 14 months. In particular, the frequency of paracentesis, the thickness of the needles used (27-gauge versus 30-gauge), the lens status, and a semi-quantitative reflux grade were analysed.
RESULTS: A paracentesis was performed in 78 cases (33%) for acute reduction of the IOP. In the 27-gauge group the frequency was 26% (25 of 96), and in the 30-gauge group 38% (53 of 138) (p = 0.05, independent estimating equation (IEE)). The medians of the semi-quantitative assessment of the reflux grade under the conjunctiva were 2.0 in the 27-gauge group (corresponding to a mild reflux) and 1.0 in the 30-gauge group (corresponding to a minimal reflux, p < 0.001, IEE).
CONCLUSIONS: When using a 30-gauge needle for intravitreal injections, the reflux under the conjunctiva was less than with a 27-gauge needle. However, the use of a 30-gauge needle appeared to be associated with a higher frequency of paracentesis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20730442     DOI: 10.1007/s00417-010-1490-y

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  15 in total

1.  Accuracy and precision of intraocular injection volume.

Authors:  Jhansi R Raju; David V Weinberg
Journal:  Am J Ophthalmol       Date:  2002-04       Impact factor: 5.258

Review 2.  Risks of intravitreous injection: a comprehensive review.

Authors:  Rama D Jager; Lloyd Paul Aiello; Samir C Patel; Emmett T Cunningham
Journal:  Retina       Date:  2004-10       Impact factor: 4.256

3.  Unsealed sclerotomy after intravitreal injection with a 30-gauge needle.

Authors:  Eduardo B Rodrigues; Carsten H Meyer; Jörg C Schmidt; Steffen Hoerle; Peter Kroll
Journal:  Retina       Date:  2004-10       Impact factor: 4.256

4.  Effect of intravitreal injections and volume changes on intraocular pressure: clinical results and biomechanical model.

Authors:  Konstantin Kotliar; Mathias Maier; Svetlana Bauer; Nikolaus Feucht; Chris Lohmann; Ines Lanzl
Journal:  Acta Ophthalmol Scand       Date:  2007-06-16

5.  Immediate intraocular pressure changes following intravitreal injections of triamcinolone, pegaptanib, and bevacizumab.

Authors:  S J Bakri; J S Pulido; C A McCannel; D O Hodge; N Diehl; J Hillemeier
Journal:  Eye (Lond)       Date:  2007-08-10       Impact factor: 3.775

6.  Necessity of paracentesis before or after intravitreal injection of bevacizumab.

Authors:  Wei-Cheng Huang; Jane-Ming Lin; Chun-Chi Chiang; Yi-Yu Tsai
Journal:  Arch Ophthalmol       Date:  2008-09

7.  Reflux after intravitreal injection of bevacizumab.

Authors:  Camiel J F Boon; Niels Crama; B Jeroen Klevering; Frederik J van Kuijk; Carel B Hoyng
Journal:  Ophthalmology       Date:  2008-07       Impact factor: 12.079

8.  Short-term course of intraocular pressure after intravitreal injection of triamcinolone acetonide.

Authors:  Matthew S Benz; Thomas A Albini; Eric R Holz; Rohit R Lakhanpal; Andrew C Westfall; Mohan N Iyer; Petros E Carvounis
Journal:  Ophthalmology       Date:  2006-05-02       Impact factor: 12.079

9.  Prevention of intraocular pressure rise following intravitreal injection.

Authors:  N Morlet; S H Young
Journal:  Br J Ophthalmol       Date:  1993-09       Impact factor: 4.638

10.  Tunneled scleral incision to prevent vitreal reflux after intravitreal injection.

Authors:  Eduardo B Rodrigues; Carsten H Meyer; Astor Grumann; Helio Shiroma; Jonathan S Aguni; Michel E Farah
Journal:  Am J Ophthalmol       Date:  2007-06       Impact factor: 5.258

View more
  3 in total

Review 1.  The safety of intravitreal bevacizumab monotherapy in adult ophthalmic conditions: systematic review.

Authors:  Edith Poku; John Rathbone; Ruth Wong; Emma Everson-Hock; Munira Essat; Abdullah Pandor; Allan Wailoo
Journal:  BMJ Open       Date:  2014-07-17       Impact factor: 2.692

2.  Immediate effect of intravitreal injection of bevacizumab on intraocular pressure.

Authors:  Ricardo Lemos-Reis; Nuno Moreira-Gonçalves; António B Melo; Angela M Carneiro; Fernando M Falcão-Reis
Journal:  Clin Ophthalmol       Date:  2014-07-23

3.  Vitreous Reflux Frequency and Intraocular Pressure After First-Time Intravitreal Aflibercept Injections: Comparison of 30- and 32-Gauge Needles.

Authors:  Tetsuya Muto; Shigeki Machida
Journal:  Clin Ophthalmol       Date:  2020-03-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.